Why India’s B.Pharm graduates need a standardised National Exit Exam
Dr Akram Ahmad, CEO & Founder, Academically Global, says that while India leads in pharma manufacturing and exports,…
Author
Exclusive interview with Dilip Singh Rathod, President India Business, JB Pharma
In this interview, Dilip Singh Rathod, President: India Business, JB Pharma, offers insights into the company's India growth…
Diagnosed prevalent cases of HER2- breast cancer across 8MM set to reach 4.12 mn in 2034
GlobalData’s latest report, reveals that the increase is partly attributed to higher survival rates of HER2- breast cancer…
Pfizer completes licensing agreement with 3SBio
The agreement allows Pfizer to manufacture and commercialise 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF…
India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025
GlobalData’s latest report reveals that Iran’s clinical trials have been affected, with 348 trials initiated in Q2, compared to…
Baxdrostat met primary, secondary endpoints in BaxHTN Phase III trial in patients with…
Baxdrostat is a potential first-in-class, highly selective aldosterone synthase inhibitor that targets the hormone driving…
Zydus gains tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
Ibrutinib tablets had annual sales of $ 2148.9 mn in the United States (IQVIA MAT May 2025)
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share
The issue is expected to raise ₹4,992.51 lakh, which will be utilised to strengthen the company’s balance sheet, support growth…
Lupin gains US FDA approvals for Liraglutide and Glucagon Injectable Products
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Session 22 of FOPE, PharmaState Academy’s PULSE Program drives compliance excellence in OSD…
The event began with a keynote address by Milan Patel, MD, Troikaa Pharmaceuticals, followed by an expert educator session by…